Kingworld Medicines Group was established in Shenzhen in 1996 and listed on the main board of the Hong Kong Stock Exchange in 2010 with stock code 01110. For more than 20 years, Kingworld Medicines Group has been adhering to the business philosophy of being proactive, sincere and altruistic, and has continuously provided global customers with safe and effective medical and health products and services. A business entity that invests in research and development, medical device production, and the big health industry. At present, the business area covers more than 34 provinces and cities across the country, Hong Kong and Macao regions and online channels. It is one of the top 100 importers of medicines and health care products in China and the top five sales of imported Chinese patent medicines.
